A new insight into the treatment of renal anemia with HIF stabilizer
Open Access
- 9 December 2020
- journal article
- review article
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 6 (1) , 1-14
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Treatment of Anemia with Darbepoetin Alfa in Systolic Heart FailureNew England Journal of Medicine, 2013
- Erythropoietin Therapy and Left Ventricular Mass Index in CKD and ESRD PatientsClinical Journal of the American Society of Nephrology, 2009
- Altitude and All-Cause Mortality in Incident Dialysis PatientsJAMA, 2009
- Prevalence and Associations of Anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004American Journal of Kidney Diseases, 2008
- Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)Journal of Clinical Investigation, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trialKidney International, 2004
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic PatientsNephron, 1997